Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0033036 (
APC
)
10,214
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Deregulation of synaptic plasticity may contribute to the pathogenesis of developmental cognitive disorders. In particular, exaggerated mGluR-dependent
LTD
is featured in fragile X syndrome, but the mechanisms that regulate mGluR-
LTD
remain incompletely understood. We report that conditional knockout of Cdh1, the key regulatory subunit of the ubiquitin ligase Cdh1-anaphase-promoting complex (Cdh1-APC), profoundly impairs mGluR-
LTD
in the hippocampus. Mechanistically, we find that Cdh1-
APC
operates in the cytoplasm to drive mGluR-
LTD
. We also identify the fragile X syndrome protein FMRP as a substrate of Cdh1-
APC
. Endogenous Cdh1-
APC
forms a complex with endogenous FMRP, and knockout of Cdh1 impairs mGluR-induced ubiquitination and degradation of FMRP in the hippocampus. Knockout of FMRP suppresses, and expression of an FMRP mutant protein that fails to interact with Cdh1 phenocopies, the Cdh1 knockout phenotype of impaired mGluR-
LTD
. These findings define Cdh1-
APC
and FMRP as components of a novel ubiquitin signaling pathway that regulates mGluR-
LTD
in the brain.
...
PMID:A Cdh1-APC/FMRP Ubiquitin Signaling Link Drives mGluR-Dependent Synaptic Plasticity in the Mammalian Brain. 2591 61